Skip to main content

Table 3 Genotype and allele distribution in normotensive and essential hypertensive participants

From: E-selectin gene polymorphisms are associated with essential hypertension: a case-control pilot study in a Chinese population

  

Total

Male

Female

SNPs

Genotype

NT(n = 495)

EH(n = 490)

P

NT(n = 293)

EH(n = 316)

P

NT(n = 202)

EH(n = 174)

P

T1880C

          

Additive

TT

2(0.4%)

3(0.6%)

0.44

2(0.7%)

3(0.9%)

0.65

0(0.0%)

0(0.0%)

0.38

 

TC

48(9.7%)

37(7.6%)

 

29(9.9%)

25(7.9%)

 

19(9.4%)

12(6.9%)

 
 

CC

445(89.9%)

450(91.8%)

 

262(89.4%)

288(91.1%)

 

183(90.6%)

162(93.1%)

 

Dominant

TT + TC

50(10.1%)

40(8.9%)

0.29

31(10.6%)

28(8.9%)

0.47

19(9.4%)

12(6.9%)

0.39

 

CC

445(89.9%)

450(91.1%)

 

262(89.4%)

288(91.1%)

 

183(90.6%)

162(93.1%)

 
 

OR

 

1.26

  

1.22

  

1.40

 
 

95% CI

 

0.82-1.96

  

0.71-2.08

  

0.66-2.98

 

Recessive

CC + TC

493(99.6%)

487(99.4%)

0.65

291(99.3%)

313(99.1%)

0.72

202(100%)

174(100%)

-

 

TT

2(0.4%)

3(0.6%)

 

2(0.7%)

3(0.9%)

 

0

0

 
 

OR

 

1.52

  

1.40

   

-

 

95% CI

 

0.25-9.13

  

0.23-8.41

  

-

 

Allele

T

52(5.3%)

43(4.4%)

0.37

33(5.6%)

31(4.9%)

0.57

19(4.7%)

12(3.4%)

0.39

 

C

938(94.7%)

937(95.6%)

 

553(94.4%)

601(95.1%)

 

385(95.3%)

336(96.6%)

 
 

OR

 

1.21

  

1.16

  

0.38

 
 

95% CI

 

0.80-1.83

  

0.70-1.91

  

0.66-2.89

 

C602A

          

Additive

CC

0(0.0%)

5(1.0%)

0.005

0(0.0%)

4(1.3%)

0.01

0(0.0%)

1(0.6%)

0.33

 

CA

21(4.2%)

38(7.8%)

 

11(3.8%)

25(7.9%)

 

10(5.0%)

13(10.6%)

 
 

AA

474(95.8%)

447(91.2%)

 

282(96.2%)

287(90.8%)

 

192(95.0%)

160(92.0%)

 

Dominant

          
 

CC + CA

21(4.2%)

43(8.8%)

0.004

11(3.8%)

29(9.2%)

0.007

10(5.0%)

14(8.0%)

0.22

 

AA

474(95.8%)

447(91.2%)

 

282(96.2%)

287(90.8%)

 

192(95.0%)

160(92.0%)

 
 

OR

 

0.461

  

0.386

  

0.595

 
 

95% CI

 

0.269-0.788

  

0.189-0.788

  

0.257-1.376

 

Recessive

          
 

AA + CA

495(100%)

485(99.0%)

0.02

293(100%)

312(98.7%)

0.05

202(100%)

173(99.4%)

0.28

 

CC

0(0%)

5(1.0%)

 

0(0%)

4(1.3%)

 

0(0%)

1(0.6%)

 
 

OR

 

1.010

  

1.013

  

1.006

 
 

95% CI

 

1.001-1.019

  

1.000-1.026

  

0.994-1.017

 

Allele

          
 

C

21(2.1%)

48(4.9%)

0.001

11(1.9%)

33(5.2%)

0.002

10(2.5%)

15(4.3%)

0.16

 

A

969(97.9%)

932(95.1%)

 

575(98.1%)

599(94.8%)

 

394(97.5%)

333(95.7%)

 
 

OR

 

0.421

  

0.347

  

0.563

 
 

95% CI

 

0.250-708

  

0.174-0.694

  

0.250-1.271

 

T1559C

          

Additive

TT

43(8.7%)

33(6.7%)

0.39

30(10.2%)

16(5.1%)

0.046

13(6.4%)

17(9.8%)

0.045

 

TC

200(40.4%)

191(39.0%)

 

115(39.2%)

124(39.2%)

 

85(42.1%)

67(38.5%)

 
 

CC

252(50.9%)

266(54.3%)

 

148(50.5%)

176(55.7%)

 

104(51.5%)

90(51.7%)

 

Dominant

TT + TC

243(49.1%)

224(45.7%)

0.29

145(49.5%)

140(44.3%)

0.20

98(48.5%)

84(48.3%)

0.96

 

CC

252(50.9%)

266(54.3%)

 

148(50.5%)

176(55.7%)

 

104(51.5%)

90(51.7%)

 
 

OR

 

1.145

  

1.232

  

1.010

 
 

95% CI

 

0.892-1.471

  

0.895-1.694

  

0.673-1.515

 

Recessive

CC + TC

452(91.3%)

457(93.3%)

0.25

263(89.8%)

300(95.0%)

0.02

189(93.6%)

157(90.2%)

0.23

 

TT

43(8.7%)

33(6.7%)

 

30(10.2%)

16(5.0%)

 

13(6.4%)

17(9.8%)

 
 

OR

 

0.759

  

0.468

  

1.574

 
 

95% CI

 

0.474-1.217

  

0.249-0.877

  

0.742-3.341

 

Allele

T

286(28.9%)

257(26.2%)

0.19

175(30.0%)

156(24.7%)

0.05

111(27.5%)

101(29.0%)

0.63

 

C

704(71.1%)

723(73.8%)

 

415(70.0%)

476(75.3%)

 

293(72.5%)

247(71.0%)

 
 

OR

 

1.143

  

1.287

  

0.926

 
 

95% CI

 

0.938-1.393

  

0.999-1.657

  

0.674-1.274

 
  1. EH, essential hypertensive group; NT, normotensive group; OR, odds ratio; 95%CI, 95% confidence interval.